<DOC>
	<DOCNO>NCT02341027</DOCNO>
	<brief_summary>This study evaluate immediate postpartum placement levonorgestrel ( LNG ) contraceptive implant within 5 day delivery improve implant utilization 6 month postpartum compare implant placement 6-8 week postpartum among woman Uganda .</brief_summary>
	<brief_title>Immediate Versus Interval Postpartum Use Levonorgestrel Contraceptive Implants : Randomized Controlled Trial</brief_title>
	<detailed_description>Waiting 6 week postpartum initiate contraception put woman risk unintended pregnancy short birth interval . Short birth interval less 18 month associate increase risk preterm delivery low birth weight infant . Subdermal implant advantageous postpartum period long-acting , reversible , highly effective , contain estrogen require intrauterine placement . In observational study postpartum continuation rate show great 95 % 6 month 86-87 % 1 year US population . Implants routinely available immediate postpartum period Uganda , availability could improve contraceptive method mix postpartum woman country . The result study may support increase access form immediate postpartum LARC ( long act reversible contraception ) develop country . This randomize , control trial association immediate postpartum contraceptive implant placement implant utilization 6 month postpartum among woman Uganda . This study compare proportion woman use Levonorgestrel contraceptive implant 6 month delivery woman randomize insertion within 5 day delivery ( immediate insertion ) 6 week delivery ( delay insertion ) . The study population woman delivery Mulago hospital Kampala , Uganda choose contraceptive implant postpartum contraception . The investigator plan enroll 202 woman plan receive postpartum Levonorgestrel contraceptive implant delivery find whether time postpartum administration implant ( prior hospital discharge 6 week delivery ) affect implant utilization , satisfaction implant , vaginal bleeding breastfeeding .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Female 18 50 year old Voluntarily request contraceptive implant postpartum contraception Vaginal delivery cesarean delivery Mulago Hospital Willing able give inform consent Agree possible home visit follow Access cellphone duration study Current breast cancer breast cancer within past 5 year Decompensated cirrhosis liver tumor Unexplained vaginal bleeding prior pregnancy Current ( plan ) use Efavirenz medication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Immediate postpartum contraception</keyword>
	<keyword>Contraceptive implant</keyword>
	<keyword>Breastfeeding</keyword>
	<keyword>Jadelle</keyword>
	<keyword>Lactation</keyword>
	<keyword>Levonorgestrel</keyword>
</DOC>